The effect of maintenance azithromycin on radiological features in patients with bronchiectasis

L. Terpstra (Alkmaar, Netherlands), J. Altenburg (Amsterdam, Netherlands), F. Mohamed Hoesein (Utrecht, Netherlands), P. De Jong (Utrecht, Netherlands), W. Boersma (Alkmaar, Netherlands)

Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis
Session: Phenotypes and endotypes of bronchiectasis
Session type: Thematic Poster
Number: 2865
Disease area: -

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Terpstra (Alkmaar, Netherlands), J. Altenburg (Amsterdam, Netherlands), F. Mohamed Hoesein (Utrecht, Netherlands), P. De Jong (Utrecht, Netherlands), W. Boersma (Alkmaar, Netherlands). The effect of maintenance azithromycin on radiological features in patients with bronchiectasis. 2865

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The bronchodilator response and clinical characteristics of patients with bronchiectasis
Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis
Year: 2019


Effects of long-term azithromycin treatment in patients with non-cystic fibrosis stable bronchiectasis
Source: Annual Congress 2007 - Infectious lung and pleural diseases
Year: 2007


The prevalence and clinical implications of bronchiectasis in patients with sarcoidosis
Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage
Year: 2019

Inter-observer variability in CT evaluation of effect of azithromycin therapy in non-cystic fibrosis bronchiectatic patients
Source: Annual Congress 2010 - Infection, inflammation and destruction
Year: 2010

The relationship between radiological severity and clinical phenotype in bronchiectasis
Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis
Year: 2019

Long-term treatment with low-dose azithromycin reduces cough, sputum production and exacerbations in patients with idiopathic diffuse bronchiectasis
Source: Eur Respir J 2004; 24: Suppl. 48, 707s
Year: 2004

Effects of exacerbation risk on symptoms and clinical characteristics in patients with bronchiectasis
Source: Annual Congress 2012 - Assessment of physical activity, exercise, muscle function and clinical characteristics as outcomes in physiotherapy and rehabilitation
Year: 2012

The radiographic bronchiectasis in patients with COPD-OSA overlap syndrome
Source: International Congress 2019 – Bronchiectasis
Year: 2019

Our clinical experience in surgical therapy of patients with bronchiectasis
Source: Eur Respir J 2002; 20: Suppl. 38, 344s
Year: 2002

Usefulness of long term treatment with azithromycin in patients with bronchiectasis (non cystic fibrosis)
Source: Annual Congress 2010 - Treatment and risk factors in lower respiratory tract infections
Year: 2010


Demographics and characteristics of antibiotic use in non-cystic fibrosis bronchiectasis patients
Source: International Congress 2016 – From pleura to bronchi: new insights
Year: 2016


Effectiveness of corticosteroids on HRCT features of COVID 19 pneumonia
Source: Virtual Congress 2021 – Diagnosis and management of COVID-19
Year: 2021


HRCT features do not predict the clinical course in children with protracted bacterial bronchitis
Source: Annual Congress 2012 - Paediatric bronchology
Year: 2012

A broad immunological screening may impact treatment in bronchiectasis patients
Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis
Year: 2019

The effect of long term low dose azithromycin on symptoms and lung function in pulmonary sarcoidosis
Source: Annual Congress 2008 - Sarcoidosis: pathophysiology and severity
Year: 2008



Effect of azithromycin treatment on inflammation in COPD patients
Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies
Year: 2019


Comparing clinical features of cases with bronchiectasis on acute and stable term
Source: Eur Respir J 2005; 26: Suppl. 49, 305s
Year: 2005

Prevalence, features of the course and treatment efficacy airway obstruction in patients with newly diagnosed pulmonary tuberculosis
Source: Annual Congress 2012 - Tuberculosis: clinical findings I
Year: 2012


The features of patients with sarcoidosis
Source: Eur Respir J 2002; 20: Suppl. 38, 436s
Year: 2002

Explorative analyses of inflammatory pathways and the effect of azithromycin in bronchiectasis patients
Source: International Congress 2019 – Bronchiectasis
Year: 2019